A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis
Clinical trial NCT01462162 · COMPLETED
Trial details
- NCT number
- NCT01462162
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-11-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.